Nicole S Arellano

6PUBLICATIONS
43CO-AUTHORS
Molecular targetsPsychopharmacologyLiquid biopsiesPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 02, 2026
Double trouble: dual-epitope targeting of mutant CALR.

Nicole S Arellano, Shannon E Elf

|Jul 17, 2025
PROTACtion against BCL-xL in post-MPN AML.

Nicole S Arellano, Shannon E Elf

|May 22, 2025
Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms.

Nicole S Arellano, William L Heaton, Mirielle C Nauman

|Nov 06, 2024
Predicting drug resistance.

Nicole S Arellano, Shannon E Elf

|Jan 31, 2024
NRAS Mutant Dictates AHCYL1-Governed ER Calcium Homeostasis for Melanoma Tumor Growth.

Chufan Cai, Jiayi Tu, Jeronimo Najarro

|Apr 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms.

Juan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz

Pageof 1

Frequent Collaborators

5 joint publications

Shannon E Elf

3 joint publications

Michele Ciboddo

2 joint publications

Ilaria Carola Casetti

2 joint publications

Daniela Pietra